Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



2 Growth Stocks for the Next Decade

The following video is part of our "Motley Fool Conversations" series, in which analyst John Reeves and advisor David Meier discuss topics across the investing world.

Over the past six months, lots of great growth companies have seen their share prices fall pretty dramatically. John and David think there are two great growth stocks out there that are very much worth buying today. The first one is InvenSense, which makes motion sensors for electronic devices, including smartphones using Google’s Android operating system. The company believes the previous issues at Qualcomm are behind it, putting InvenSense squarely back on the growth track.

The other stock is MAKO Surgical. The company has hit a slow patch, which is never good for a growth company. But its installed base of orthopedic surgical robots should help influence the next round of purchases. It may not be the next Intuitive Surgical, but it’s got a great shot. As with any growth stock, it’s important to take a long-term view. There will be ups and downs. But if the business has a good product and a big market to serve, the odds of success go up. That’s why John and David own both of these companies in their real-money portfolio.

The recent market sell-off of MAKO Surgical shares has some folks wondering whether the potential growth prospects of the robotic surgery company make it a buy today or a stock to be wary of. Read our premium report to catch up on the details of MAKO's story. Click here to access it now.  


David Meier owns shares of InvenSense. John Reeves owns shares of Google. The Motley Fool owns shares of Google, InvenSense, Intuitive Surgical, MAKO Surgical, and Qualcomm. Motley Fool newsletter services recommend Google, Intuitive Surgical, and MAKO Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (6) | Recommend This Article (8)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On August 05, 2012, at 10:48 AM, philipcarl31 wrote:

    Newsflash for the Motley Fool Fools: You have lost credability with this cappy MAKO pick.

  • Report this Comment On August 05, 2012, at 10:49 AM, philipcarl31 wrote:


  • Report this Comment On August 23, 2012, at 9:41 PM, CMFMelange wrote:


  • Report this Comment On September 20, 2012, at 4:52 PM, TMFSymington wrote:

    @philipcarl31...still at it are we?

    Anyone who listened to when they made their first calls is still up big, and anyone who listened to them when they wrote the "punishment doesn't fit the crime" and was a great buy after last quarter's earnings announcement was treated to a 55% gain since the beginning of August.

    Unless you dove in headfirst with a full position, how about adding to your position to average down instead of complaining because of your higher cost basis?

    You shouldn't blame anyone but yourself for losses.

    For some context with MAKO, though, I think quote 18 from this article today fits quite nicely:

  • Report this Comment On September 20, 2012, at 4:54 PM, TMFSymington wrote:

    Here's the quote if you don't want to click the link:

    18. "Sometimes buying early on the way down looks like being wrong, but it isn't."

    -- Seth Klarman

    Buying early and on the way down is not always easy, though. Studies have shown that a drop in prices hurts twice as much as an equal gain in prices improves your sentiment. But if we understand how a business works and why it has a long-term competitive advantage, then buying more at lower prices can pay off handsomely.

  • Report this Comment On September 20, 2012, at 5:02 PM, TMFSymington wrote:

    One last comment and I'll be quiet...

    Please stop to think before claiming the credibility of this (or ANY) investing site can be lost over the short term performance of a single stock. If that's your basis for maintaining credibility, then it's safe to say nobody on this planet is can be declared credible in your eyes.

    Also remember this isn't a short term game, as evidenced by the title "2 Growth Stocks for the Next Decade."

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1969985, ~/Articles/ArticleHandler.aspx, 10/23/2016 12:27:34 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 18,145.71 -16.64 -0.09%
S&P 500 2,141.16 -0.18 -0.01%
NASD 5,257.40 15.57 0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 4:00 PM
GOOGL $824.06 Up +2.43 +0.30%
Alphabet (A shares… CAPS Rating: *****
INVN $7.33 Up +0.12 +1.66%
InvenSense CAPS Rating: *****
ISRG $678.02 Down -3.80 -0.56%
Intuitive Surgical CAPS Rating: ****
MAKO.DL $0.00 Down +0.00 +0.00%
MAKO Surgical CAPS Rating: ****
QCOM $67.93 Up +0.59 +0.88%
Qualcomm CAPS Rating: ****